Fosun International

Fosun Foundation and Longfor Group donated 40 ventilators to the U.S. hospitals in fight against COVID-19

Friday, May 29, 2020 - 7:00pm

NEW YORK, May 29, 2020 /PRNewswire/ -- Fosun Foundation together with Longfor Group announce the donation of 40 Breas Vivo 50 ventilators to the hospitals in 21 hospitals located in 11 different states of U.S. to support medical communities fighting againse the COVID-19.

Key Points: 
  • NEW YORK, May 29, 2020 /PRNewswire/ -- Fosun Foundation together with Longfor Group announce the donation of 40 Breas Vivo 50 ventilators to the hospitals in 21 hospitals located in 11 different states of U.S. to support medical communities fighting againse the COVID-19.
  • Breas Medical Group has also donated 140 non-invasive ventilators to 14 Hubei hospitals in Feb. 2020.
  • As an enterprise with global organizational capabilities, Fosun is willing to take the initiative to fulfill due responsibilities for our global community.
  • Therefore, in November 2012, Fosun Foundation was registered as a philanthropic organization in Shanghai for achieving Fosun's social responsibility.

Wowotalent: Harvest twelve years of value over five years

Monday, May 11, 2020 - 7:00am

The current situation is unpredictable, say investors, and risk in new investment projects has increased significantly.

Key Points: 
  • The current situation is unpredictable, say investors, and risk in new investment projects has increased significantly.
  • At the same time, they could say that a platform that insists on being responsible for investor funds and caring about the development of entrepreneurial projects is invaluable.
  • WOWO has more than 9 years of headhunting industry experience in the real estate and Internet sectors, accumulating significant business resources.
  • From August to December 2019, the WOWO (Beijing) Network and Fosun Group successfully hosted the first WOWO Innovation Camp.

Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa

Wednesday, April 29, 2020 - 5:50pm

Since the COVID-19 outbreak, Fosun Pharma, an international pharmaceutical company, has taken an active part in the battle.

Key Points: 
  • Since the COVID-19 outbreak, Fosun Pharma, an international pharmaceutical company, has taken an active part in the battle.
  • Mr. Wu Yifang, President and CEO of Fosun Pharma, said, "Fosun Pharma has been operating in Africa for over decade and has nearly 1,000 employees there.
  • We are striving to control the spread of the epidemic by strengthening various case management measures."
  • Fosun Pharma hopes that these materials will help alleviate the burden on local health systems, facilitating the countries to reach their malaria prevention and control targets.

Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit

Sunday, April 19, 2020 - 1:00pm

SHANGHAI, April 19, 2020 According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK) has received emergency use authorization (EUA) from FDA for itsCOVID-19 RT-PCR detection kit.

Key Points: 
  • SHANGHAI, April 19, 2020 According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK) has received emergency use authorization (EUA) from FDA for itsCOVID-19 RT-PCR detection kit.
  • The testing kit which was self-developed by Fosun Long March, a wholly-owned subsidiary of Fosun Pharma, has received the medical device registration certificate issued by the China National Medical Products Administration (NMPA) and granted CE certification from the European Union ("EU").
  • Fosun Pharma has been engaged in the business of PCR hepatitis B virus diagnostic reagents since its establishment in 1994.
  • According to the company's FY2019 earnings results, the revenue of Fosun Pharma increased by 14.72% to RMB28,585million as compared to 2018.

From China to the World, Fosun's Fight against COVID-19 Continues

Tuesday, April 7, 2020 - 2:57pm

Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world.

Key Points: 
  • Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world.
  • Chen Qiyu, Co-CEO of Fosun International and Chairman of Fosun Pharma, expressed his gratitude to the experts from all over the world.
  • Chen said: "Since January 23, Fosun's Wuhan Jihe Hospital is listed as a COVID-19 designated treatment hospital.
  • We have invested in the fight against the epidemic in all aspects.

From China to the World, Fosun's Fight against COVID-19 Continues

Tuesday, April 7, 2020 - 2:49pm

Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world.

Key Points: 
  • Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world.
  • Chen Qiyu, Co-CEO of Fosun International and Chairman of Fosun Pharma, expressed his gratitude to the experts from all over the world.
  • Chen said: "Since January 23, Fosun's Wuhan Jihe Hospital is listed as a COVID-19 designated treatment hospital.
  • We have invested in the fight against the epidemic in all aspects.

Fosun Continues Joining Hand with Other Benevolent Enterprises in Donating Medical Supplies, to Hospitals in the U.S.

Wednesday, April 1, 2020 - 4:29pm

In response to the increasing numbers of global coronavirus pneumonia patients, Fosun's "Global Anti-Virus Relief Scheme" is continuing its efforts.

Key Points: 
  • In response to the increasing numbers of global coronavirus pneumonia patients, Fosun's "Global Anti-Virus Relief Scheme" is continuing its efforts.
  • The total donated materials include 69,700 masks and 2,300 medical suits.
  • Together we keep calm, unite to fight, and carry on," said Fosun International's Chairman Guo Guangchang.
  • This is Fosun's first batch of medical protection supplies to the US since Fosun has kicked off its second phase of operations against the coronavirus.

BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China

Monday, March 16, 2020 - 6:00am

If approved, Fosun Pharma will commercialize the vaccine in China.

Key Points: 
  • If approved, Fosun Pharma will commercialize the vaccine in China.
  • BioNTech will supply the mRNA vaccine for clinical trials from GMP manufacturing facilities in Europe along with its partner Polymun .
  • Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd (Fosun Pharma, Stock Symbol: 600196.SH, 02196.HK) is a leading healthcare group founded in China.
  • These forward-looking statements may include, but may not be limited to, the ability of BioNTech and Fosun Pharma to develop and commercialize a vaccine for COVID-19; the potential for a broader collaboration between BioNTech and Fosun Pharma; and the ability to consummate an equity investment by Fosun Pharma in BioNTech.

Fosun RZ Capital's Investment in Molecular Data Inc., provides more opportunities in the Industrial Internet market

Monday, January 6, 2020 - 1:45am

SHANGHAI, Dec. 31, 2019 /PRNewswire/ -- Fosun RZ Capital invested in Molecular Data's B+ Round Financing, becoming one of the most important investors for Molecular Data.

Key Points: 
  • SHANGHAI, Dec. 31, 2019 /PRNewswire/ -- Fosun RZ Capital invested in Molecular Data's B+ Round Financing, becoming one of the most important investors for Molecular Data.
  • Molecular Data is a leading technology-driven platform in China's chemical industry, connecting participants along the chemical value chain through integrated solutions.
  • After long-term layout, Fosun RZ Capitalhas expanded its focus to several major industries, such as B2B transaction platform (Molecular Data), logistics supply chains, finance/insurance, education and so on.
  • After the IPO of Molecular Data, Fosun RZ Capital will control more power in the Industrial Internet.

AM Best Affirms Credit Ratings of Peak Reinsurance Company Limited and Its Subsidiary

Wednesday, December 18, 2019 - 6:35pm

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of a- of Peak Reinsurance Company Limited (Peak Re) (Hong Kong) and its subsidiary, Peak Reinsurance AG (Switzerland).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of a- of Peak Reinsurance Company Limited (Peak Re) (Hong Kong) and its subsidiary, Peak Reinsurance AG (Switzerland).
  • A deterioration in the credit profile of Fosun International Holdings Ltd., Peak Res major shareholder, may also impose a negative impact on Peak Res ratings.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper media use of Bests Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Bests Credit Ratings and AM Best Rating Action Press Releases .